Most drug candidates fail clinical trials, in many cases because the compounds have less than optimal physico-chemical properties. A new method for assessing the 'drug-likeness' of compounds might help to remedy the situation.
References
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S. & Hopkins, A. L. Nature Chem. 4, 90–98 (2012).10.1038/nchem.1243
Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Adv. Drug Delivery Rev. 23, 3–25 (1997).
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M. & Leeson, P. D. J. Med. Chem. 46, 1250–1256 (2003).
Hughes, J. D. et al. Bioorg. Med. Chem. Lett. 18, 4872–4875 (2008).
Luker, T. et al. Bioorg. Med. Chem. Lett. 21, 5673–5679 (2011).
Leeson, P. D. & Springthorpe, B. Nature Rev. Drug Discov. 6, 881–890 (2007).
Leeson. P. D. & St-Gallay, S. A. Nature Rev. Drug Discov. 10, 749–765 (2011).
Hann, M. M. Med. Chem. Commun. 2, 349–355 (2011).
Wager, T. T. et al. ACS Chem. Neurosci. 1, 435–449 (2010).
Lajiness, M. S., Maggiora, G. M. & Shanmugasundaram, V. J. Med. Chem. 47, 4891–4896 (2004).
Teague, S. J., Davis, A. M., Leeson, P. D. & Oprea, T. Angew. Chem. Int. Edn 38, 3743–3748 (1999).
Bunnage, M. E. Nature Chem. Biol. 7, 335–339 (2011).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leeson, P. Chemical beauty contest. Nature 481, 455–456 (2012). https://doi.org/10.1038/481455a
Published:
Issue Date:
DOI: https://doi.org/10.1038/481455a
- Springer Nature Limited
This article is cited by
-
HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy
Nature Communications (2023)
-
Design, Synthesis, Drug-Likeness and In Silico Prediction of Polycyclic Aromatic Schiff base Tethered Organosilatranes
Silicon (2023)
-
Lipid-Based Drug Delivery System (LBDDS): An Emerging Paradigm to Enhance Oral Bioavailability of Poorly Soluble Drugs
Biomedical Materials & Devices (2023)
-
Highly potent natural fungicides identified in silico against the cereal killer fungus Magnaporthe oryzae
Scientific Reports (2022)
-
Molecular modeling piloted analysis for semicarbazone derivative of curcumin as a potent Abl-kinase inhibitor targeting colon cancer
3 Biotech (2021)